Live Breaking News & Updates on மருந்து ப்ரைஸிஂக் ப்ரோக்ர்யாம்
Stay updated with breaking news from மருந்து ப்ரைஸிஂக் ப்ரோக்ர்யாம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AHF Thanks HHS for Clarifying Rules on 340B Drug Pricing; Blasts Pharma's Greed marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.
In Featured, News by Ged Kenslea December 30, 2020 On Wednesday, the HHS Office of the General Counsel released an advisory opinion concluding that drug manufacturers are required to deliver discounts under the 340B Drug Pricing Program on covered outpatient drugs when contract pharmacies are acting as agents of 340B covered entities
they planned to refuse to provide certain drugs at the legally required ‘340B price’ as required by section 340B of the U.S. Public Health Services Act WASHINGTON (December 30, 2020) AIDS Healthcare Foundation (AHF) welcomed and praised an advisory opinion issued earlier today by the Office of the General Counsel for the United States Health and Human Services Department (HHS) which concluded that drug manufacturers are required to deliver discounts under the 340B Drug Pricing Program on covered outpatient drugs when contract pharmacies are acting as agents of 340B covered entities. (HHS press release) ....
Aging Inmates Squeeze Health-Care Budgets As prisoners get older and develop expensive health problems, states are looking for ways to cut costs. Caroline Cournoyer | March 2011 Prison, it’s been said, is a microcosm of society. In the case of health care, that is certainly true. Just like the rest of us, the prison population is getting older and, as a result, sicker. They need more and more expensive health care, which they have a right to receive under the 8th Amendment’s ban on cruel and unusual punishment. That’s putting a tight squeeze on corrections budgets across the country. ....
To print this article, all you need is to be registered or login on Mondaq.com. On December 10, 2020, the U.S. Department of Health and Human Services ( HHS ), Health Resources and Services Administration ( HRSA ) issued a long-anticipated regulation of interest to drug makers and providers: the 340B Drug Pricing Program Alternative Dispute Resolution Final Rule ( ADR Final Rule ). 1 The ADR Final Rule establishes an alternative dispute resolution ( ADR ) process that offers manufacturers and 340B covered entities a means of negotiating certain disputes in a more formal setting without resorting to litigation or private arbitration. In the ADR Final Rule, HRSA notes that its intention ....
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news. Week in Review Highlight of the Week: On Wednesday, HHS finalized its review of Phase 3 Provider Relief Fund applications and began distribution of the funds. Read more about this action and other news below. I. Regulations, Notices & Guidance On December 14, 2020, the Department of Health and Human Services (HHS), along with several other agencies, issued a final rule entitled, Equal Participation of Faith-Based Organizations in the Federal Agencies’ Programs and Activities. This rule provides clarity about the rights and obligations of faith-based organizations participating in the Agencies’ Federal financial assistance programs and activities. This rulemaking is intended to ensure tha ....